Management impact of imaging brain vesicular monoamine transporter type 2 in clinically uncertain parkinsonian syndrome with 18F-AV133 and PET
PK Alexander, Y Lie, G Jones… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Idiopathic Parkinson disease is a common neurodegenerative disorder for which
misdiagnosis occurs in up to 30% of patients after initial assessment and in 10%–15% even …
misdiagnosis occurs in up to 30% of patients after initial assessment and in 10%–15% even …
[HTML][HTML] Network diffusion model predicts neurodegeneration in limb-onset Amyotrophic Lateral Sclerosis
Objective Emerging evidences suggest that the trans-neural propagation of phosphorylated
43-kDa transactive response DNA-binding protein (pTDP-43) contributes to …
43-kDa transactive response DNA-binding protein (pTDP-43) contributes to …
Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study …
PK Alexander, Y Lie, V Dore, S Bozinovski… - BMJ open, 2018 - bmjopen.bmj.com
Objectives To further validate the diagnostic utility of 18F-AV-133 vesicular monoamine
transporter type 2 (VMAT2) positron emission tomography (PET) in patients with clinically …
transporter type 2 (VMAT2) positron emission tomography (PET) in patients with clinically …
RapidAI Compared With Human Readers of Acute Stroke Imaging for Detection of Intracranial Vessel Occlusion
LA Slater, N Ravintharan, S Goergen… - Stroke: Vascular and …, 2024 - Am Heart Assoc
Background Rapid detection of intracranial arterial occlusion in patients with ischemic stroke
is important to facilitate timely reperfusion therapy. We compared the diagnostic accuracy of …
is important to facilitate timely reperfusion therapy. We compared the diagnostic accuracy of …
Automated and objective analysis of speech in premanifest and early-stage Huntington's disease
Background Clinical markers that show change in performance in people with Huntington's
disease (HD) during the presymptomatic and prodromal stages remain a target of …
disease (HD) during the presymptomatic and prodromal stages remain a target of …
[HTML][HTML] Neurodegenerative disorders: a multidisciplinary approach to care
Y Lie - Medicine Today, 2023 - medicinetoday.com.au
People living with neurodegenerative disorders have diverse and complex needs that
demand a multidisciplinary approach to care, with GPs being key members of the team …
demand a multidisciplinary approach to care, with GPs being key members of the team …
J14 Subcutaneous haloperidol for chorea in patients with Huntington's disease and dysphagia
SCM Lee, I Jayasinghe, Y Lie - 2022 - jnnp.bmj.com
In Huntington's Disease (HD), severe dysphagia can impede oral intake of medication,
including medications for chorea. Here we describe how this was managed in our neuro …
including medications for chorea. Here we describe how this was managed in our neuro …
The management impact of [18F] AV-133 VMAT2 PET in atypical Parkinson's disease
1847 Objectives Imaging vesicular monoamine transporters (VMAT2) measures the integrity
of the presynaptic dopaminergic system. We assessed the impact on diagnosis, clinical …
of the presynaptic dopaminergic system. We assessed the impact on diagnosis, clinical …
[CITATION][C] Speech is a Sensitive Marker in Premanifest Huntington's Disease: Acoustic Features and Their Relationship to Cognition and Fine-Motor Performance
J Chan, Y Lie, J Stout, A Vogel - …, 2020 - SPRINGER ONE NEW YORK …